<- Go Home
Lite Strategy, Inc.
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.
Market Cap
$71.7M
Volume
44.2K
Cash and Equivalents
$18.0M
EBITDA
-$17.1M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$9.00
52 Week Low
$1.46
Dividend
N/A
Price / Book Value
0.79
Price / Earnings
-0.84
Price / Tangible Book Value
0.79
Enterprise Value
$53.7M
Enterprise Value / EBITDA
-3.14
Operating Income
-$17.5M
Return on Equity
63.84%
Return on Assets
-36.57
Cash and Short Term Investments
$18.0M
Debt
N/A
Equity
$16.9M
Revenue
N/A
Unlevered FCF
-$15.5M
Sector
Biotechnology
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium